Effects of modulators of sarcoplasmic Ca2+ release on the development of skeletal muscle fatigue.
The reduced release of Ca2+ from sarcoplasmic reticulum (SR) is considered a major determinant of muscle fatigue. In the present study, we investigated whether the presence of dantrolene, an established inhibitor of SR Ca2+ release, or caffeine, a drug facilitating SR Ca2+ release, modifies muscle fatigue development. Accordingly, the effects of Ca2+ release modulators were analyzed in vitro in mouse fast-twitch [extensor digitorum longus (EDL)] and slow-twitch (soleus) muscles, fatigued by repeated short tetani (40 Hz for 300 ms, 0.5 s(-1) in soleus and 60 Hz for 300 ms, 0.3 s(-1) in EDL, for 6 min). Caffeine produced a substantial increase of tetanic tension of both EDL and soleus muscles, whereas dantrolene decreased tetanic tension only in EDL muscle. In both EDL and soleus muscles, 5 microM dantrolene did not affect fatigue development, whereas 20 microM dantrolene produced a positive staircase during the first 3 min of stimulation in EDL muscle and a slowing of fatigue development in soleus muscle. The development of the positive staircase was abolished by the addition of 15 microM ML-7, a selective inhibitor of myosin light chain kinase. On the other hand, caffeine caused a larger and faster loss of tension in both EDL and soleus muscles. The results seem to indicate that the changes in fatigue profile induced by caffeine or dantrolene are mainly due to the changes in the initial tetanic tension caused by the drugs, with the resulting changes in the level of contraction-dependent factors of fatigue, rather than to changes in the SR Ca2+ release during fatigue development.
Germinario
E
E
Department of Human Anatomy and Physiology, University of Padova, 35131 Padova, Italy.
Esposito
A
A
Megighian
A
A
Midrio
M
M
Betto
R
R
Danieli-Betto
D
D
D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D024722:Cardiac Myosins / Q000378:metabolism; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D003620:Dantrolene / Q000494:pharmacology*; D015180:Electrophoresis, Gel, Two-Dimensional; D051379:Mice; D009119:Muscle Contraction / Q000502:physiology; D018763:Muscle Fatigue / Q000502:physiology*; D009125:Muscle Relaxants, Central / Q000494:pharmacology*; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism*; D018994:Myosin Light Chains / Q000378:metabolism; D010766:Phosphorylation; D012519:Sarcoplasmic Reticulum / Q000187:drug effects* / Q000378:metabolism
D000697:Central Nervous System Stimulants; D009125:Muscle Relaxants, Central; D018994:Myosin Light Chains; C107184:myosin light chain 2; D002110:Caffeine; D024722:Cardiac Myosins; D003620:Dantrolene; D002118:Calcium